Search Medical Condition
Please enter condition
Please choose location

Non-Small Cell Lung Cancer Clinical Trials

A listing of Non-Small Cell Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (523) clinical trials

The relatively restricted C4.4a expression pattern provides a target for the selective delivery of a cytotoxic drug to C4.4.a-expressing tumor cells by means of a suitable antibody-drug conjugate. The subject population eligible for the current study will be those subjects with advanced malignancies known to express C4.4a, which are refractory ...

Phase

Study to evaluate the long-term safety and efficacy of Darbepoetin Alfa in anemic subjects with Advanced Stage Non-small Cell Lung Cancer receiving multi-cycle chemotherapy. Patient Inclusion Criteria: Subjects with metastatic (stage IV) Non-small Cell Lung cancer, receiving or about receive first line cyclic chemotherapy, life expectancy >6 months, 18 years ...

Phase

Patients with non-small cell lung cancer who have failed two or more prior treatment regimens, to determine overall survival Patient Inclusion Criteria: 18+ years of age, confirmed stage IIIB or non-small cell lung cancer, failed at least 2 prior systemic anti-cancer regimens, disease progression, Patient Exclusion Criteria: Presence of brain ...

Phase

First-line treatment for patients with non-squamous non-small cell lung cancer Patient Inclusion Criteria: Confirmed diagnosis, at least one measurable target lesion, 18+ years of age, life expectancy of >12 weeks Patient Exclusion Criteria: Small cell or carcinoid lung cancer patients are ineligible, untreated brain metastases, history of active malignancy in ...

Phase

First-line induction and maintenance therapy for the treatment of patients with Stage IV NSCLC Patient Inclusion Criteria: Must have a histologic or cytologic diagnosis of advance NSCLC, may not have received any prior systemic chemotherapy, 18 + years of age Patient Exclusion Criteria: Have a known central nervous system disease, ...

Phase